Global mRNA Drug Market Growth 2023-2029
The global mRNA Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for mRNA Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for mRNA Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for mRNA Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key mRNA Drug players cover Moderna, Pfizer, Zydus Cadila, Fosun Pharma, CureVAC, Sri Lankan Microorganisms, BioNtech, AstraZeneca and Janssen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Messenger RNA (mRNA) is a single-stranded long ribonucleic acid that can transmit genetic information in DNA and synthesize proteins through translation. After mRNA enters the body, specific proteins can be expressed by autologous cells, avoiding the influence of in vitro factors; it can regulate the human immune system through endogenous expression of functional proteins, and eliminate autologous threats including cancer cells. The mRNA vaccine encoding the antigenic sequence is introduced into cells through a delivery platform such as lipid nanocarriers, and then human cells produce antigens through translation to activate the immune response.
LPI (LP Information)' newest research report, the “mRNA Drug Industry Forecast” looks at past sales and reviews total world mRNA Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected mRNA Drug sales for 2023 through 2029. With mRNA Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world mRNA Drug industry.
This Insight Report provides a comprehensive analysis of the global mRNA Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on mRNA Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global mRNA Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for mRNA Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global mRNA Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Drug market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Preventive Vaccines
Therapeutic Vaccine
Therapeutic Drugs
Segmentation by application
Hospital
Clinic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Moderna
Pfizer
Zydus Cadila
Fosun Pharma
CureVAC
Sri Lankan Microorganisms
BioNtech
AstraZeneca
Janssen
Key Questions Addressed in this Report
What is the 10-year outlook for the global mRNA Drug market?
What factors are driving mRNA Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do mRNA Drug market opportunities vary by end market size?
How does mRNA Drug break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Please note: The report will take approximately 2 business days to prepare and deliver.